Article
Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
5 Jun 2017
Abstract excerpt
The prognosis of bladder urothelial carcinoma (BLCA) varies greatly even for patients with similar pathological characteristics. We conducted transcriptome sequencing on ten pairs of BLCA samples and adjacent normal tissues to identify differentially expressed genes. Anillin (ANLN) was identified as a transcript that was significantly up-regulated in BLCA samples compared with normal tissues. Prognostic power of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
